Ticlopidine, Platelets and Vascular Disease /
This book summarizes the current research on the efficacy and safety of Ticlopidine as an agent for preventing stroke.
| Main Author: | |
|---|---|
| Corporate Author: | |
| Other Authors: | |
| Format: | eBook |
| Language: | English |
| Published: |
New York, NY :
Springer New York,
1993.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- From the contents: W.K. Hass, J.D. Easton: On the Proximate Causal Mechanisms of Ischemic Stroke and Myocardial Infarction
- E. Panak: A Review of Ticlopidine Development
- P. Teitelbaum: Pharmacokinetics and Pharmacodynamics of Ticlopidine in Animals and Man
- L.A. Harker: The Unique Mechanism of Action of Ticlopidine on Human Platelets in Contrast to Other Antiplatelet Agents
- W. Pryse-Phillips: Clinical Studies of Stroke Prevention with Ticlopidine in Man
- L. Janzon: Clinical Trials of Ticlopidine in Patients with Intermittent Claudication
- F. Balsano: Clinical Trials of Ticlopidine in Patients with Coronary Artery Disease
- M.L. Dyken: Systematic Overviews of Randomized Trials of Antiplatelet Agents for Prevention of Stroke, Mycocardial Infarction and Vascular Death
- V. Molony: An Analysis of the Side Effects of Ticlopidine
- J.D. Easton: The Role of Ticlopidine in Stroke Prevention: A Cost-Risk-Benefit Analysis
- W.K. Hass: Epilogue: The Virtues of Imperfection.